Found: 94
Select item for more details and to access through your institution.
Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice--a longitudinal analysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Kaposiform Hemangioendothelioma of the GI Tract: An Exception to Occam's Principle in an Adult with SBO.
- Published in:
- Case Reports in Oncological Medicine, 2019, p. 1, doi. 10.1155/2019/3269326
- By:
- Publication type:
- Article
A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific region.
- Published in:
- Orphanet Journal of Rare Diseases, 2014, v. 9, n. 1, p. 2, doi. 10.1186/s13023-014-0137-1
- By:
- Publication type:
- Article
A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific region.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice-a longitudinal analysis.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 1, p. 283, doi. 10.1007/s00520-014-2375-0
- By:
- Publication type:
- Article
Predicting response to immunotherapy in non-small cell lung cancer-from bench to bedside.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1225720
- By:
- Publication type:
- Article
Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: A case series.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 2, p. 174, doi. 10.1111/j.1743-7563.2010.01345.x
- By:
- Publication type:
- Article
Número necessário a tratar (NNT) e custo por evento evitado (COPE) de enzalutamida e acetato de abiraterona para o tratamento de câncer de próstata resistente à castração que falharam a terapia de privação de androgênio.
- Published in:
- JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde, 2016, v. 8, n. 2, p. 141, doi. 10.21115/JBES.v8.n2.p141-148
- By:
- Publication type:
- Article
Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1929, doi. 10.1111/dom.15509
- By:
- Publication type:
- Article
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.
- Published in:
- Lung Cancer: Targets & Therapy, 2024, v. 15, p. 87, doi. 10.2147/LCTT.S463429
- By:
- Publication type:
- Article
Distributed Reactive Power Injection-Based Approach for Minimization of Losses in Electrical Networks Considering Heuristic Algorithms and Voltage Deviation.
- Published in:
- Energies (19961073), 2023, v. 16, n. 19, p. 6761, doi. 10.3390/en16196761
- By:
- Publication type:
- Article
Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 1, p. 1, doi. 10.1007/s11912-011-0202-z
- By:
- Publication type:
- Article
Maximum power point tracking algorithm for photovoltaic systems considering error minimization and power derivative.
- Published in:
- International Journal of Emerging Electric Power Systems, 2021, v. 22, n. 3, p. 297, doi. 10.1515/ijeeps-2020-0220
- By:
- Publication type:
- Article
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1177, doi. 10.1007/s00262-020-02536-5
- By:
- Publication type:
- Article
Does a "Western Lifestyle" Confer a Higher Burden of Colorectal Cancer? A Comparison of EU15+ Countries versus Global Trends between 1990 and 2019.
- Published in:
- Cancers, 2024, v. 16, n. 12, p. 2277, doi. 10.3390/cancers16122277
- By:
- Publication type:
- Article
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1572, doi. 10.3390/cancers16081572
- By:
- Publication type:
- Article
Lung Cancer Incidence by Detailed Race–Ethnicity.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2164, doi. 10.3390/cancers15072164
- By:
- Publication type:
- Article
Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 ("Omicron") SARS-CoV-2 Variant Wave.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4629, doi. 10.3390/cancers14194629
- By:
- Publication type:
- Article
Validating an Instrument for Direct Patient Reporting of Distress and Chemotherapy-Related Toxicity among South African Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 95, doi. 10.3390/cancers14010095
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2614, doi. 10.3390/cancers13112614
- By:
- Publication type:
- Article
Bayo Lapawol (Let Their Voices Be Heard): Haitian Women's Barriers to and Facilitators of Cervical Cancer Prevention and Control.
- Published in:
- Health Education & Behavior, 2021, v. 48, n. 6, p. 873, doi. 10.1177/1090198121990381
- By:
- Publication type:
- Article
Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives.
- Published in:
- 2017
- By:
- Publication type:
- Report
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States.
- Published in:
- 2016
- By:
- Publication type:
- Report
VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 151, n. 3, p. 481, doi. 10.1007/s10549-015-3410-7
- By:
- Publication type:
- Article
Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- Report
Erratum to: Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- Report
A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 137, n. 1, p. 187, doi. 10.1007/s10549-012-2326-8
- By:
- Publication type:
- Article
Impact of biomarkers on clinical trial risk in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 136, n. 1, p. 179, doi. 10.1007/s10549-012-2247-6
- By:
- Publication type:
- Article
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- Report
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 123, n. 2, p. 427, doi. 10.1007/s10549-010-1002-0
- By:
- Publication type:
- Article
Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature.
- Published in:
- Clinical Rheumatology, 2004, v. 23, n. 2, p. 152, doi. 10.1007/s10067-003-0816-0
- By:
- Publication type:
- Article
Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2346223, doi. 10.1001/jamanetworkopen.2023.46223
- By:
- Publication type:
- Article
Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 3, p. e234261, doi. 10.1001/jamanetworkopen.2023.4261
- By:
- Publication type:
- Article
Racial/ethnic disparities in curative‐intent treatment for early‐stage non‐small cell lung cancer patients among heterogeneous Black populations: US‐born Black, Afro‐Haitian, West Indian Black, and Hispanic Black.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 19, p. 1, doi. 10.1002/cam4.7449
- By:
- Publication type:
- Article
Does biomarker use in oncology improve clinical trial failure risk? A large‐scale analysis.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 6, p. 1955, doi. 10.1002/cam4.3732
- By:
- Publication type:
- Article
Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 8, p. 1847, doi. 10.1002/cam4.1101
- By:
- Publication type:
- Article
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 6, p. 1143, doi. 10.1002/cam4.1001
- By:
- Publication type:
- Article
Training of oncologists: results of a global survey.
- Published in:
- Ecancermedicalscience, 2020, v. 14, n. 1063-1111, p. 1, doi. 10.3332/ecancer.2020.1074
- By:
- Publication type:
- Article
Implementation of diagnostic resources for cancer in developing countries: a focus on PET/CT.
- Published in:
- Ecancermedicalscience, 2019, v. 13, n. 890-910, p. 1, doi. 10.3332/ecancer.2019.ed87
- By:
- Publication type:
- Article
Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: Preliminary evidence of activity in small cell and neuroendocrine carcinomas.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 7, p. 1413, doi. 10.1002/cncr.22522
- By:
- Publication type:
- Article
Avanzando Caminos (Leading Pathways): design and procedures of the Hispanic/Latino Cancer Survivorship Study.
- Published in:
- American Journal of Epidemiology, 2024, v. 193, n. 7, p. 940, doi. 10.1093/aje/kwae033
- By:
- Publication type:
- Article
Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study.
- Published in:
- Sao Paulo Medical Journal, 2020, v. 138, n. 6, p. 505, doi. 10.1590/1516-3180.2018.0256170919
- By:
- Publication type:
- Article
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article